» Articles » PMID: 39722826

Prevalence and Risk Factors of Osteopenia in Adults with Short Bowel Syndrome: a Retrospective Longitudinal Cohort Study

Overview
Specialty General Medicine
Date 2024 Dec 26
PMID 39722826
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Metabolic Bone Disease (MBD) is common in patients with short bowel syndrome (SBS). This study was to investigate the incidence and risk factors of osteopenia in adult SBS patients.

Methods: Hospital records from January 2010 to December 2019 were used to identify all eligible patients. Logistic regression and a nomogram were used to analyze the data.

Results: A total of 120 patients with SBS were included in this study, and 76 patients (63.3%) developed osteopenia during the 10-year observation period, The multivariate analysis using the logistic regression model demonstrated that age (OR = 1.070; 95%CI: 1.016-1.126,  = 0.010), female (OR = 5.098; 95%CI: 1.211-21.456,  = 0.026), tumor history (OR = 4.481; 95%CI: 1.125-17.854,  = 0.033), duration of SBS (OR = 1.0862; 95%CI: 1.022-1.103,  = 0.002) and remnant ileum (OR = 4.260; 95%CI: 1.210-15.002,  = 0.024) were independent risk factors for osteopenia in adults with SBS. The area under the curve (AUC) for the joint model (age, female, tumor history, duration of SBS, remnant ileum) was 0.848 and the corresponding sensitivity and specificity were 0.855 and 0.705, respectively. The C-index was 0.849 (95% CI: 0.778-0.917); thus, the predictions made by the model were close to the actual outcomes. In the decision curve analysis, the nomogram performed well and was feasible to make beneficial clinical decisions.

Conclusion: This study reveals the high prevalence of osteopenia in SBS patients and highlights the importance of early identification and treatment of osteopenia. A nomogram may provide personalized prediction and guidance for medical intervention.

References
1.
Haderslev K, Jeppesen P, Hartmann B, Thulesen J, Sorensen H, Graff J . Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon. Scand J Gastroenterol. 2002; 37(4):392-8. DOI: 10.1080/003655202317316006. View

2.
Li S, Gao L, Zhang X, He J, Fu W, Liu Y . Genetically Low Vitamin D Levels, Bone Mineral Density, and Bone Metabolism Markers: a Mendelian Randomisation Study. Sci Rep. 2016; 6:33202. PMC: 5021966. DOI: 10.1038/srep33202. View

3.
Man P, van der Meer I, Lips P, Middelkoop B . Vitamin D status and bone mineral density in the Chinese population: a review. Arch Osteoporos. 2016; 11:14. PMC: 4819723. DOI: 10.1007/s11657-016-0265-4. View

4.
Ceylan M, Akdas S, Yazihan N . Is Zinc an Important Trace Element on Bone-Related Diseases and Complications? A Meta-analysis and Systematic Review from Serum Level, Dietary Intake, and Supplementation Aspects. Biol Trace Elem Res. 2020; 199(2):535-549. DOI: 10.1007/s12011-020-02193-w. View

5.
Che J, Yang J, Zhao B, Zhang G, Wang L, Peng S . The Effect of Abnormal Iron Metabolism on Osteoporosis. Biol Trace Elem Res. 2019; 195(2):353-365. DOI: 10.1007/s12011-019-01867-4. View